158 related articles for article (PubMed ID: 38428661)
1. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
3. Total flavonoids of Taraxacum mongolicum inhibit non-small cell lung cancer by regulating immune function.
Kang L; Miao MS; Song YG; Fang XY; Zhang J; Zhang YN; Miao JX
J Ethnopharmacol; 2021 Dec; 281():114514. PubMed ID: 34384846
[TBL] [Abstract][Full Text] [Related]
4. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
[TBL] [Abstract][Full Text] [Related]
5. Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells.
Yan F; Wang X; Xie Y; Liu X; Yu L; Wang P; Li T; Wang S; Li W; Yang Z
Phytomedicine; 2021 Oct; 91():153722. PubMed ID: 34488188
[TBL] [Abstract][Full Text] [Related]
6. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract][Full Text] [Related]
7. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
Li XY; Ma K; Yan JN; You FC; Ma L
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
[TBL] [Abstract][Full Text] [Related]
8. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
[TBL] [Abstract][Full Text] [Related]
9. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
10. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
12. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
13. [Role of COX-2/PGE2/EP4 Axis-induced Macrophage Functional Activation
in NSCLC Development].
Zhao J; Zhu Q; Zhang Y; Li G; Zhang Y; Li F; Bian L
Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):245-256. PubMed ID: 38769827
[TBL] [Abstract][Full Text] [Related]
14. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
[TBL] [Abstract][Full Text] [Related]
15. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
[TBL] [Abstract][Full Text] [Related]
17. Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1.
Gong B; Wang L; Zhang H; Wang Q; Li W
Cell Biochem Funct; 2024 Jan; 42(1):e3925. PubMed ID: 38269509
[TBL] [Abstract][Full Text] [Related]
18. Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.
Luo B; Wang P; Tian J; Chu X; Lu X; Yang Y; Zhou Y; Li Y; Que Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116885. PubMed ID: 37422099
[TBL] [Abstract][Full Text] [Related]
19. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
20. Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments.
Peng H; Huang Z; Li P; Sun Z; Hou X; Li Z; Sang R; Guo Z; Wu S; Cao Y
J Ethnopharmacol; 2024 Mar; 321():117518. PubMed ID: 38042385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]